CN106729438A - A kind of medicine of therapeutic community's property retinitis - Google Patents
A kind of medicine of therapeutic community's property retinitis Download PDFInfo
- Publication number
- CN106729438A CN106729438A CN201710062045.5A CN201710062045A CN106729438A CN 106729438 A CN106729438 A CN 106729438A CN 201710062045 A CN201710062045 A CN 201710062045A CN 106729438 A CN106729438 A CN 106729438A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- retinitis
- root
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 206010038910 Retinitis Diseases 0.000 title claims description 20
- 230000001225 therapeutic effect Effects 0.000 title claims description 9
- 241000255789 Bombyx mori Species 0.000 claims abstract description 6
- 241000427159 Achyranthes Species 0.000 claims abstract description 5
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 5
- 244000241257 Cucumis melo Species 0.000 claims abstract description 5
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims abstract description 5
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 5
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 5
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 5
- 241000270666 Testudines Species 0.000 claims abstract description 5
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims abstract description 5
- 125000003118 aryl group Chemical group 0.000 claims abstract description 5
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 5
- 235000013976 turmeric Nutrition 0.000 claims abstract description 5
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 4
- 241000521581 Millettia Species 0.000 claims abstract description 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 208000001749 optic atrophy Diseases 0.000 abstract 2
- 239000006187 pill Substances 0.000 abstract 2
- 241000258920 Chilopoda Species 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 201000010099 disease Diseases 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 210000001508 eye Anatomy 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 10
- 230000004438 eyesight Effects 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 230000000007 visual effect Effects 0.000 description 8
- 206010010904 Convulsion Diseases 0.000 description 7
- 230000036461 convulsion Effects 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 201000007737 Retinal degeneration Diseases 0.000 description 6
- 210000001525 retina Anatomy 0.000 description 6
- 201000004569 Blindness Diseases 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 241000723353 Chrysanthemum Species 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 206010000269 abscess Diseases 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004377 improving vision Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 230000004382 visual function Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 200000000007 Arterial disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000006373 Bell palsy Diseases 0.000 description 1
- 235000016811 Biondella Nutrition 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000003569 Central serous chorioretinopathy Diseases 0.000 description 1
- 208000033379 Chorioretinopathy Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000001344 Macular Edema Diseases 0.000 description 1
- 206010025415 Macular oedema Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010063341 Metamorphopsia Diseases 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 238000003457 Shi epoxidation reaction Methods 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241001530209 Swertia Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 235000008326 Trichosanthes anguina Nutrition 0.000 description 1
- 244000078912 Trichosanthes cucumerina Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 210000003161 choroid Anatomy 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 210000002189 macula lutea Anatomy 0.000 description 1
- 201000010230 macular retinal edema Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 201000006470 prosopagnosia Diseases 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000004283 retinal dysfunction Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 239000000790 retinal pigment Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 210000000162 simple eye Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000005211 surface analysis Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of active pills for improving acuity of sight for optic atrophy, pharmaceutical technology field, is to solve the problems, such as optic atrophy, it is characterized in that by following making raw material and preparation method：First, Chinese medicine material used：15 parts of root tuber of aromatic turmeric, 15 parts of stiff silkworm, 1 part of pearl powder, 15 parts of cornu bubali, 15 parts of earthworm, 8 parts of centipede, 15 parts of yncaria stem with hooks, 15 parts of reticulate millettia, 15 parts of the root of bidentate achyranthes, 10 parts of Ligusticum wallichii, 20 parts of chrysanthemum, melon wither 20 parts, 20 parts of turtle shell, 7 parts of Radix Glycyrrhizae；2nd, pill will be pressed into after each Chinese medicine co-grinding.
Description
Technical field
The present invention relates to the medicine of central retinitis, more particularly to the medicine of traditional Chinese medical herbal treatment, belong to
Medicine technology field.
Background technology
Central retinitis or central serous chorioretinopathy.This disease is generation in the orphan of macula area
Vertical exudative chorioretinopathy, with subretinal Neovascularization and bleeding.It is strong that this disease is more common in 20-40 Sui green grass or young crops
Year, asexuality difference, how simple eye morbidity.Due to seepage, bleeding, the machine of new vessels, scar is eventually formed, make central vision
Permanent lesion.The reason for causing this sick is more, and many cases of China may be relevant with tuberculosis, viral infection.
Central retinitis shows as somebody and finds to regard thing such as in cloud and mist, seemingly has scrim to cover at the moment, depending on thing hair
Secretly, think that there is one piece of very thin shadow in visual field center, shadow is changeable, sometimes metamorphopsia, two eyes see thing size
Different, it is smaller that sick eye regards thing.This is, due to hydrops under macula retinae area oedema or macula lutea, to make retina uneven caused, this
The property retinitis or Central Serous retina fat network film lesion centered on disease.This disease is a kind of very common eyeground
Disease, eyes are not red not bitterly during morbidity, and surface is not seen ill.Mostly occur in 20~40 years old person between twenty and fifty, male is many far beyond women.
One eye of normal infringement, also has eyes to send out patient once in a while, and morbidity is more and catches a cold, work is tired, nervous, has not enough sleep or excessive
Smoking, drink etc. it is relevant.Therefore, it is believed that this disease is caused by macular area arteriolar spasm.
Central retinitis can be by fluorescence fundus angiography inspection, it can be seen that macular area shades, macular edema,
In oedema edge visible circular, oval or random scatters halation, about 1~3 such as papilla diameter size.Diseased region can go out
Existing yellow-white or canescence ooze out dot, the reflective disappearance of central fovea or disperse originally.After edema extinction, central fovea is reflective extensive
Multiple, the lighter can not stay any vestige, and eyesight is also unaffected.Most patient's diseased regions leave pigment deposition or a small amount of pigment is de-
Fall, visual function has impaired in various degree.
Preferably, the patient's eyesight of first attack 90% can recover normal to the general prognosis of central retinitis.But easily recurrence,
If multiple relapse, eyesight can suffer permanent lesion.To mild cases, this disease has the tendency of untreated and self-healing.
Central retinitis is a kind of disease for having self-healing to be inclined to, and real pathogenic factor is not also fully aware of.Therefore, exist
It is generally anti symptom treatment in treatment.Drug therapy, laser therapy, injection treatment, traditional Chinese medical herbal treatment etc. can be taken.
It is a kind of difficult diseases in ophthalmology that central retinitis develops into retinal pigment degeneration, is referred to as not controlling it
Disease, is a kind of Genetic chronic illness in eye for being primary in malnutritive to retina, involves eyes more, and domestic patient about 300,000, full generation
Boundary treaty 3,000,000, its clinical characters show as early stage yctalopia, visual field concentric contraction, finally the visual field in a tubular form, lose the sight of both eyes or frequency
Face blindness, sizable ratio is occupied in illness in eye of blinding.Retinal pigment degeneration (RP) belongs to heredity retinal rod, cone cell
Dystrophic disease.Reduced with yctalopia, the visual field, eyeground osteocyte sample pigmentation is characterized.Recent decades domestic and international ophthalmology
The multinomial basic research in boundary is confirmed：" retinal pigment degeneration is relevant with choroidal blood flow reduction ", yctalopia, tubular visual field formation it is pre-
Show that choroidal blood flow cannot meet the metabolic demand of rod cell, with CC region blood circulation function reduction
It is corresponding.I passes through to states such as China, Japan, the U.S., Germany, Kazakhstan, Burma, Mongolia, Philippine, Canada at center
More than 3000 example patients of family confirm that early, mid-term patient passes through operative treatment after implementing " autologous vein materials Doppler flow mapping sets up art "
Eyesight can in various degree be improved, widened the vision, eyeground improves total effective rate up to 96%；Patients with terminal can effectively prevent the state of an illness from entering
Exhibition, delays blindness.Preclinical medicine promotes clinical medicine progress.It is micro- with domestic external eyes that operation clinical practice demonstrates this operation designing
Circulation theory achievement in research matches.The denaturation of apparent wind membranochromic pigments is to be primary in net choroid malnutrition, with retinal pigment
Skin, retinal dysfunction are a kind of inborn genetic diseases causing blindness of main clinical manifestation.China's population risk about 1/
4000, have more than 30 ten thousand, whole world patient more than 300 ten thousand.Clinical manifestation is early stage yctalopia, and visual field progressive constriction, severe patient is in pipe
Shape, final central vision declines gradually blindness or frequency faces blindness.
Patient is once making a definite diagnosis retinal pigment degeneration（Incurable disease）Conclusion cause great psychologic damage to patient, together
When also to family's cloud of happiness, toss about in bed treatment, very long career of seeking medical advice makes us worn out mentally and physically, finally but breaks away from not
The misfortune of blindness.Significant curative effect acquired by the repeated clinical practice that this project experienced up to 18 years, by perioperatively
Visual electrophsiology contrasting detection is confirmed.Retrieved through Academy of Medical Sciences Institute of Medical Information of state, conclusion：Visual electrophsiology can be caused
The treatment method of improvement has no identical home and abroad document report.Though retinal pigment degeneration category genetic disease, retina,
Choroidal microcirculation obstacle serves vital effect in the generation, evolution of this disease.Motherland's this disease of medical science is called "
High wind cataract ", " pigmentary degeneration of the retina with the pupil golden in colour ", it is not enough native endowment.Proposed the seventies to improve choroidal microcirculation by Soviet Union ophthalmologist, oculist
Treat this disease；Britain ophthalmology scholar confirms within 90 years：Retinal pigment degeneration is relevant with choroidal blood flow reduction；This theoretical 99 years again
It is secondary to be confirmed using Doppler's detection by Beijing Tongren Hospital's Yang Wen profits etc..Managed according to retinitis pigmentosa and changed, in this
The heart makes the big blood vessel of ectochoroidae, the cyclic metabolism in retina Shan Hang areas obtain bright using offshoot circulation operative treatment is set up
Aobvious to improve, visual function is reversed.Broken a new path to cure patients with retinitis pigmentosa.
The content of the invention
In order to solve the problems, such as the treatment problem regarding central retinitis, it is necessary to carry out normal solution to central retinitis
Medical pathologies are analyzed, and with the traditional Chinese medicine analysis center property retinitis, belong to the deficiency of liver-yin and kidney-yin, and kidney essence deficiency adds damp and hot rising, wind
Phlegm closes god, and loss of nutrient of eyes, treatment should be treated with nourishing liver and kidney, inrigorating qi and promoting blood circulation, Chinese traditional medicine composition that is clearing and activating the channels and collaterals, clearing liver and improving vision.
The remedy measures that a kind of medicine solve problem of therapeutic community's property retinitis is taken are by following Chinese medicine matter
Amount part ratio is combined：15 parts of cultivated land, 12 parts of Fructus Corni, 15 parts of root tuber of aromatic turmeric, 15 parts of stiff silkworm, 1 part of pearl powder, 15 parts of cornu bubali,
15 parts of dragon, 15 parts of yncaria stem with hooks, 15 parts of reticulate millettia, 15 parts of the root of bidentate achyranthes, 10 parts of Ligusticum wallichii, 20 parts of chrysanthemum, melon wither 20 parts, 20 parts of turtle shell, Radix Glycyrrhizae 7
Part.
Each herbal nature effect in a kind of lower medicine of therapeutic community's property retinitis of surface analysis.Cultivated land is sweet, tepor；Return
Liver and kidney channel；Health-care effect：Cultivated land is enriched blood, enriching yin, production of sperm mends marrow, health-care；It is agent first of enriching blood, for blood deficiency chlorosis, dizzy
Dizzy palpitaition, insomnia and irregular menstruation.Effect of Fructus Corni and effect：Filling liver kidney, puckery vital essence, Gu collapse.Soreness of waist and knee joint is controlled, it is dizzy
Dizzy, tinnitus, impotence, seminal emission, frequent urination, liver cold of insufficiency type heat, incessant sweating due to debility, the heart shakes arteries and veins and dissipates.Root tuber of aromatic turmeric has promoting blood circulation and pain relieve, promoting the circulation of qi solution
Strongly fragrant, clear away heart-fire cool blood, the effect of soothing liver-gallbladder, also with regulation immunity, improves blood circulation, effect that Green Tea Extract is damaged；
The all pains of smelting chest and abdomen side of body rib, the mistake heart is demented, pyreticosis coma, spits blood, bleeding from five sense organs or subcutaneous tissue.Effect of stiff silkworm and effect:Stiff silkworm alias flying worm, deadlock
Worm, white bombys batryticatus；There are dispelling wind and relieving convulsion, effect of reducing phlegm and resolving masses；For convulsion, abscess of throat, submandibular lymph nodes inflammation, facial nerve
Paralysis.It is dried orange peel bitter, pungent, it is warm in nature.Effect of pearl powder and effect:Refreshing and detoxicating, arresting convulsion of calming the nerves, except screen myogenic, clear liver and improve vision,
Except face spot, antidiarrheal, except children's fever (of children) accompanied by fear, only peace soul, seminal emission gonorrhoea, solution acne treatment poison.Cornu bubali, Chinese medicine name.It is Chinese medicine rhinoceros horn
Substitute, function has heat-clearing, cool blood, arresting convulsion, removing toxic substances.Cornu bubali controls typhoid fever temperature epidemic disease heat invading xuefen, shies mad, irritated, delirium, spot
Rash, jaundice is spitted blood, bleeding from five sense organs or subcutaneous tissue, lower blood, swollen ulcer drug, hardship, cold, the thoughts of returning home, Liver Channel.Earthworm control pyreticosis shy mad, child convulsion, cough and asthma,
The diseases such as hot eyes of having a headache, abscess of throat, urinary obstruction, Fengshi Guanjie pain, hemiplegia.Yncaria stem with hooks The flat liver of heat-clearing, relieve dizziness, high fever, infantile convulsions, epilepsy, etc. arresting convulsion.Chicken
The promoting blood circulation of blood rattan, relaxing muscles and tendons, control soreness of waist and knee joint, paralysis and numbness.Felwort is bitter in taste, puckery, Great Cold, nontoxic.Cure mainly fever and chills, frightened disease between bone
Perverse trend, after wound absolutely, determines the five internal organs, desinsection poison.The root of bidentate achyranthes, bitter, acid are mild-natured；Return liver and kidney channel；Filling liver kidney；Strengthening the bones and muscles；Invigorate blood circulation；
Draw enemy state（Fire）It is descending；Inducing diuresis for treating strangurtia；Main soreness of waist and knee joint；Flaccidity and weakness of the lower limbs；Amenorrhea due to stagnation of blood；Dysmenorrhoea；Postpartum abdominal pain due to blood stasis；Levy lump in the abdomen；
Placenta retension；Heat gonorrhea；Blood strangury；Traumatic injury；Carbuncle swells dislikes sore；Abscess of throat.Ligusticum wallichii has blood-activating and qi-promoting, wind-expelling pain-stopping；For pacifying
Comfort neural, positive head wind headache, abdominal mass stomachache, chest side of body shouting pain, tumbling and swelling, headache, arthralgia pain due to rheumatism.Chrysanthemum is expansible coronal dynamic
Arteries and veins, increases CBF, and hypotensive, coronary artery dilator and antibacterial are drunk can adjust myocardial function for a long time, reduce cholesterol, right
Coronary heart disease, hypertension, the too high disease of artery sclerosis, serum cholesterol has good curative effect.The major function that melon withers is heat-clearing
Phlegm, relieving stuffiness of the chest by dispersing aggregation of pathogens, moisturize laxation, detumescence and apocenosis.Instruction：Snakegourd Fruit has coronary artery dilating, anti-cardiac muscle to cardiovascular system
Ischemic, improvement microcirculation.Turtle shell replenishing the vital essence and removing heat, calming the liver to stop the wind, softening and resolving hard mass, nourishing and suppressing Yang, Zhi Laore hectic fever due to yin, wind formation from yin deficiency,
Malaria with general debility malaria is female, Disorder lump in the abdomen Xuan addictions, is leaked through amenorrhoea, pediatric epilepsy scared.Radix Glycyrrhizae is kobadrin medicine, and effect is rather extensive, in Chinese medicine
In decoction and Chinese patent drug compatibility, its tonifying Qi benefit spleen is commonly used and the effect of middle emergency, coordinating the drug actions of a prescription.
A kind of beneficial effect of the medicine of therapeutic community's property retinitis is：A kind of medicine of therapeutic community's property retinitis
Invention adds damp and hot rising, wind phlegm and closes by with the traditional Chinese medicine analysis center property retinitis, belonging to the deficiency of liver-yin and kidney-yin, kidney essence deficiency
God, loss of nutrient of eyes, treatment should be treated with nourishing liver and kidney, inrigorating qi and promoting blood circulation, Chinese traditional medicine composition that is clearing and activating the channels and collaterals, clearing liver and improving vision；Medical science is managed
It is correct by analysis, receive obvious therapeutic effect.
Specific embodiment
A kind of medicine of therapeutic community's property retinitis is combined by following traditional Chinese medicine quality part ratio：15 parts of cultivated land,
12 parts of Fructus Corni, 15 parts of root tuber of aromatic turmeric, 15 parts of stiff silkworm, 1 part of pearl powder, 15 parts of cornu bubali, 15 parts of earthworm, 15 parts of yncaria stem with hooks, reticulate millettia 15
Part, 15 parts of the root of bidentate achyranthes, 10 parts of Ligusticum wallichii, 20 parts of chrysanthemum, melon wither 20 parts, 20 parts of turtle shell, 7 parts of Radix Glycyrrhizae.Application method：Patient day takes a box
Ten, divide 3 ~ 4 times and take.Taken effect by typically taking a box dose, treatment time is 2 ~ 3 months.
Claims (1)
1. a kind of medicine of therapeutic community's property retinitis, it is characterized in that being combined by following drug quality part ratio：Cultivated land 15
Part, 12 parts of Fructus Corni, 15 parts of root tuber of aromatic turmeric, 15 parts of stiff silkworm, 1 part of pearl powder, 15 parts of cornu bubali, 15 parts of earthworm, 15 parts of yncaria stem with hooks, reticulate millettia
15 parts, 15 parts of the root of bidentate achyranthes, 10 parts of Ligusticum wallichii, 20 parts of chrysanthemum, melon wither 20 parts, 20 parts of turtle shell, 7 parts of Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710062045.5A CN106729438A (en) | 2017-01-30 | 2017-01-30 | A kind of medicine of therapeutic community's property retinitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710062045.5A CN106729438A (en) | 2017-01-30 | 2017-01-30 | A kind of medicine of therapeutic community's property retinitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106729438A true CN106729438A (en) | 2017-05-31 |
Family
ID=58955185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710062045.5A Withdrawn CN106729438A (en) | 2017-01-30 | 2017-01-30 | A kind of medicine of therapeutic community's property retinitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106729438A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103656290A (en) * | 2013-12-11 | 2014-03-26 | 张有富 | Medicine for treating optic atrophy and preparation method of medicine |
| CN104042894A (en) * | 2014-06-30 | 2014-09-17 | 毛长龙 | Medicine for treating optic atrophy and preparation method thereof |
| CN106267023A (en) * | 2016-09-30 | 2017-01-04 | 李先强 | A kind of active pills for improving acuity of sight for optic atrophy |
-
2017
- 2017-01-30 CN CN201710062045.5A patent/CN106729438A/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103656290A (en) * | 2013-12-11 | 2014-03-26 | 张有富 | Medicine for treating optic atrophy and preparation method of medicine |
| CN104042894A (en) * | 2014-06-30 | 2014-09-17 | 毛长龙 | Medicine for treating optic atrophy and preparation method thereof |
| CN106267023A (en) * | 2016-09-30 | 2017-01-04 | 李先强 | A kind of active pills for improving acuity of sight for optic atrophy |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104606513B (en) | A kind of Chinese medicine for treating cardiovascular and cerebrovascular disease and preparation method thereof | |
| CN102579918A (en) | Traditional Chinese medicine composition for treating glaucoma as well as preparation method and administration mode of same | |
| CN106491987A (en) | A kind of treat traditional Chinese medicine fumigating steaming liquid of cataract and preparation method thereof | |
| CN102631557A (en) | Traditional Chinese medicine composition for treating cataract, external oculopathy, presbyopia and myopia and preparation method thereof | |
| CN104306880A (en) | Formula of traditional Chinese medicine for treating cerebral thrombosis | |
| CN107837380A (en) | A kind of Chinese medicine composition for treating cancer pain and preparation method thereof | |
| CN102755549B (en) | Drug for curing cataract and preparation method thereof | |
| CN106729438A (en) | A kind of medicine of therapeutic community's property retinitis | |
| CN105998495A (en) | Traditional Chinese medicine composition for treating scald and preparation method thereof | |
| CN104383152A (en) | Traditional Chinese medicine preparation for treating glaucoma and preparation method of traditional Chinese medicine preparation | |
| CN107617081A (en) | The Chinese medicine composition and its preparation and preparation method of a kind of hair growth | |
| CN104523981A (en) | Traditional Chinese medicine preparation for treating optic neuritis and preparation method | |
| CN117815349A (en) | Traditional Chinese medicine composition for treating meningioma and preparation method thereof | |
| CN104306546A (en) | A traditional Chinese medicine composition used for treating optic atrophy, and decoctions, pills and powder of the composition | |
| CN107875297A (en) | A kind of Chinese medicine composition for treating vertigo and preparation method thereof | |
| CN108514631A (en) | A kind of drug and preparation method thereof for treating cardiac neurosis | |
| CN103550455B (en) | Traditional Chinese medicine for treating glaucoma | |
| CN102225105B (en) | Medicine for treating migraine | |
| CN106729402A (en) | It is a kind of to treat medicine of encephalatrophy disease and preparation method thereof | |
| CN106491730A (en) | A kind of treat Chinese medicine composition of glaucoma and preparation method thereof | |
| CN106215133A (en) | A kind of can effective Chinese medicine composition treating cervical spondylosis and preparation method thereof | |
| CN105148118B (en) | A kind of Chinese medicine composition medicament and preparation method thereof for treating xerophthalmia | |
| CN1062165C (en) | Medicinal cream for curing myopia and weak visual acuity | |
| CN104524036A (en) | Traditional Chinese medicine preparation for treating optic neuritis and preparation method thereof | |
| CN105055948A (en) | Health-preserving porridge for prevention of cerebral infarction and cerebral hemorrhage and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170531 |